Michael Elliot Shankman's most recent trade in Lexaria Bioscience Corp was a trade of 50,000 Stock Options done . Disclosure was reported to the exchange on May 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lexaria Bioscience Corp | Michael Elliot Shankman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 50,000 | 100,000 | - | - | Stock Options |